When Placebo Plus Standard of Care Clouds the Signal: Unmasking the âPlacebo Problemâ in Lupus Clinical Trials

Dr. Juan Ovalles, Senior Director of Rheumatology at Indero, discusses how high placebo response rates driven by background therapy complicate lupus drug trials, and outlines evolving strategies in trial design, clinical practice, and pharmacist-led care to ensure investigational biologics are fairly evaluated and appropriately used in systemic lupus erythematosus. Read More